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Hormonal variations during the menstrual cycle (MC) may influence trainability of strength. We investigated the effects
of a follicular phase-based strength training (FT) on muscle strength, muscle volume and microscopic parameters,
comparing it to a luteal phase-based training (LT).
Eumenorrheic women without oral contraception (OC) (N = 20, age: 25.9 ± 4.5 yr, height: 164.2 ± 5.5 cm, weight:
60.6 ± 7.8 kg) completed strength training on a leg press for three MC, and 9 of them participated in muscle biopsies.
One leg had eight training sessions in the follicular phases (FP) and only two sessions in the luteal phases (LP) for
follicular phase-based training (FT), while the other leg had eight training sessions in LP and only two sessions in FP for
luteal phase-based training (LT). Estradiol (E2), progesterone (P4), total testosterone (T), free testosterone (free T) and
DHEA-s were analysed once during FP (around day 11) and once during LP (around day 25). Maximum isometric force
(Fmax), muscle diameter (Mdm), muscle fibre composition (No), fibre diameter (Fdm) and cell nuclei-to-fibre ratio (N/F)
were analysed before and after the training intervention.
T and free T were higher in FP compared to LP prior to the training intervention (P < 0.05). The increase in Fmax after FT
was higher compared to LT (P <0.05). FT also showed a higher increase in Mdm than LT (P < 0.05). Moreover, we found
significant increases in Fdm of fibre type ΙΙ and in N/F only after FT; however, there was no significant difference from
LT. With regard to change in fibre composition, no differences were observed between FT and LT. FT showed a higher
gain in muscle strength and muscle diameter than LT.
As a result, we recommend that eumenorrheic females without OC should base the periodization of their strength
training on their individual MC.
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In past decades, it has repeatedly been verified that
serum concentrations of luteinizing hormone (LH),
follicle-stimulation hormone (FSH), estradiol (E2) and
progesterone (Prog) fluctuate during the menstrual cycle
and that the level of androstenedione and testosterone
reaches its peak prior to, or at the time of ovulation
(Longcope 1986, Van Look and Baird 1980). This fluctuation
of hormones during the menstrual cycle may influence 1)
acute exercise performance during the respective phase,
and 2) the trainability of muscle strength in a period
when hormone milieu favours gain in muscle mass
(Constantini et al. 2005; Janse de Jonge 2003; Lebrun 1994).* Correspondence: petra.platen@rub.de
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in any medium, provided the original work is pA number of studies on the effects of the menstrual
cycle on exercise performance, however, show conflicting
results. The above mentioned reviewers revealed in their
newest available overviews in this topic that some studies
showed a higher strength during the follicular phase
than during the luteal phase whereas other studies
reported the highest strength during the mid-luteal
phase, while the majority of studies could not find
any alteration in muscle strength over the menstrual
cycle (Constantini et al. 2005; Janse de Jonge 2003;
Lebrun 1994). In the recent 10 years only three studies
on variation of muscle strength across the menstrual cycle
that included hormone analysis for verification of the
phase of the menstrual cycle when subjects were tested
were found. None of them did find any effect of the phase
of the menstrual cycle on isokinetic peak torque of knee
extensors/flexors and maximum isometric strength ofOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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voluntary isometric force of the first dorsal interos-
seus muscle (Elliott et al. 2003), or on handgrip
strength and isokinetic muscle strength of knee extensors
(peak torque), muscle endurance and one leg hop test
(Fridén et al. 2003).
The effects of the phase of the menstrual cycle on
trainability of strength in humans are even less clear, even
though the available empirical evidence is promising.
The only strength training intervention study using
the different hormonal milieu of FP and LP as modulators
of training adaptability analysed the possible divergent
effects of training stimuli in either FP or LP on the amount
of strength gain in healthy women (Reis et al. 1995). The
authors described a higher trainability of strength of
one-leg knee extensor muscles in 7 women when the
respective leg was mainly trained for 4 weeks in FP
compared to a training periodization without regarding
the phase of the cycle. Despite the small number of
subjects and wide inter-individual variability all subjects of
this study showed higher strength adaptations during the
follicular-phase based training.
One possible link between MC-depending training
induced increases in muscle mass is the fluctuation of
steroid hormones throughout the cycle and their possible
effects on protein synthesis. The effects of estrogens on the
human muscle have mainly been investigated in peri- and
postmenopausal women. The striking decline in muscle
strength occurring during the perimenopausal and
postmenopausal period can be reversed by hormone
replacement therapy (Bergström 1962; Jabbour et al. 2006).
Discovery of 3 types of estrogen receptors has led to
the finding that estrogen may govern the regulation
of a number of downstream genes and molecular targets
(Enns and Tiidus 2010; Lowe et al. 2010). Very recently
estrogen receptor α and ß have been shown to be involved
in muscle differentiation including slow myosin-heavy
chain isoform (MHC) which is the dominant MHC
isoform in type I fibres (Pellegrini et al. 2014) indicating
that estrogens might influence muscle fibre type distribu-
tion. Further, one recent study reported that those women
using hormone replacement therapy had significantly
greater up-regulation of pro-anabolic gene expression both
at rest and following eccentric exercise compared to a
control group (Dieli-Conwright et al. 2009). Estrogens
may also positively influence post-damage repair processes
through activation and proliferation of satellite cells
which are well known mechanism for skeletal muscle
cell adaptation after a (strength) training stimulus
(Enns and Tiidus 2010). Furthermore, it has recently
been postulated that the beneficial effect of estrogens
on muscle strength is accomplished by improving the
intrinsic quality of skeletal muscle, whereby fibres are
enabled to generate force, i.e. myosin strongly binds toactin during contraction, which might also lead to higher
strength gains during training (Lowe et al. 2010).
Several recent clinical trials have indicated that testoster-
one supplementation at physiological doses in androgen-
deficient women induce improvements in lean body mass
clearly indicating the pro-anabolic effects of low-level
testosterone on female skeletal muscle. These physiological
effects may be critical for athletic performance and strength,
albeit the effects of testosterone supplementation in women
with serum androgen concentrations within the normal
range has not been studied (Enea et al. 2011).
Only very few data exist on the physiological effects
of progesterone (P4) on the female skeletal muscle
cell. Recent studies have consistently found amino
acid oxidation and protein degradation to be greater
in the luteal phase (LP) compared with the follicular
phase (FP) at rest and during exercise. It appears that P4
is responsible for the consistent finding of increased
protein catabolism in LP, while estrogens may reduce
protein catabolism (Oosthuyse and Bosch 2010).
All these studies support the hypothesis that estrogen
and testosterone induce anabolic effects and progesterone
has more katabolic effects on the skeletal muscle and that
timing of strength training according to hormone concen-
trations might affect skeletal muscle adaptions. Indeed, Reis
et al. (1995) did include analysis of steroid hormones in the
above mentioned strength training intervention study. In
short, they found estradiol in the training period being
positively correlated with the muscle cross sectional
area, estradiol before the training period being positively
correlated with the development of maximal strength after
one menstrual cycle, changes of progesterone between the
luteal phases being negatively correlated with the develop-
ment of maximal strength, and testosterone in the training
period being positively correlated with the changes of
the muscle cross sectional area. Although the authors
summarised that the sample was very small and correlations
do not necessarily represent cause-and-effect relationships,
they concluded that the findings of their study suggest to
consider not only testosterone and free testosterone but
additionally the characteristic female hormones like estra-
diol and progesterone when investigating the interrelations
between the physical performance and the endocrine system
of female athletes.
Overall, the existing data indicate a more anabolic state
in FP and the peri-ovulatory phase of the MC, compared to
a more catabolic state in LP. No study, however, has so far
combined the analysis of strength, macroscopic and cellular
parameters after menstrual-cycle triggered training.
Therefore the aim of the present study was to investigate
the effects of menstrual cycle phase-based strength train-
ing on strength, macroscopic and microscopic muscle
adaptations in a controlled training intervention study
in healthy young females.
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Subjects
20 healthy eumenorrheic women (mean (± SD) age: 25.9 ±
4.5 yr, height: 164.2 ± 5.5 cm, weight: 60.6 ± 7.8 kg)
volunteered to participate in this study. Subjects were
either untrained or moderately trained students from the
university who partly participated in sport programs like
aerobics or yoga. Some of them used a bicycle for transpor-
tation purposes. All subjects performed less than 2 hours of
regular physical training per week. No one was experienced
in or was currently performing resistance training. Subjects
had not been taking oral contraceptives (OC) or any other
hormonal treatments during the year prior to participation
in this study and had no history of any endocrine disorders.
All subjects had regular menstrual cycles (28.6 ± 2.3 days),
and basal body temperature increased during the luteal
phase of each cycle. Prior to the study, participants were
informed about the purpose, procedures and risks of the
study, however were not informed about the underlying
hypotheses in order to avoid influence of motivation espe-
cially on maximal strength diagnosis. Blinding of training
frequency concerning the phase of the menstrual cycle was
not possible. Written informed consent was obtained from
each participant. Approval for the study was obtained
from the Ethics Committee of the Medical Faculty of
Ruhr-University Bochum, Germany.
Experimental design
This study was a controlled trial where the effects of
two different menstrual cycle-based leg strength training
programs were compared to each other (follicular phase-
based- (FT) versus luteal phase-based training (LT)). Every
participant performed both programs at the same time:
one program with one leg, the other program with the
other leg. To eliminate effects of a preference for one body
side, the assignment of training programs to body sides
was performed by randomization. The duration of the
study for the individual participant was based on the
length of the menstrual cycle. The entire study took five
MC (two control cycles followed by three training cycles)
which was equivalent to about 140 days considering that
one menstrual cycle took approximately 28 days.
Throughout the whole study period the individual
menstrual cycle integrity was analysed by measurements
of basal body temperature and documented in a menstrual
cycle calendar. If no clear increase in body temperature
could be demonstrated around the middle of any of the
menstrual cycles the subject was excluded from the
study. Four subjects were excluded according to missing
mid-cycle increase in body temperature. The remaining
n = 20 subjects all had detectable increments of mid-cycle
basal body temperature in each of five menstrual cycles.
In the second control cycle and in each training cycle,
blood samples for hormonal analysis were taken from acubital vein on day 11 (late follicular phase) and on day 25
(late luteal phase) of the menstrual cycle when cycle
length was between 27 and 29 days. When cycle length
was between 30 and 31 days, venous blood was collected
on day 13 and on day 27, and when cycle length was
between 25 and 26 days, venous blood was collected on
days 9 and 23. The condition of blood sampling was
strictly standardized. Blood was taken between 8 and 9 am
after an overnight fasting with the subjects staying in
supine position. Strength of maximum isometric knee
extension (Fmax) was measured around day 11 and around
day 25 of the menstrual cycle, according to the individual
length of the cycle. The sum of the diameters of rectus
femoris, vastus intermedius and vastus lateralis muscle
(Mdm) were measured on day 25 and muscle biopsies
were taken from vastus lateralis muscle on day 27.
Strength training was performed throughout the three
consecutive training cycles. Fmax was repeatedly measured
throughout the training period on day 14 and on day 27
in each training cycle. In the third training cycle, the
investigations which had been performed in the second
control cycle (blood sampling, Fmax, Mdm, muscle biopsy)
were repeated on the respective days.
We did not control for diet during the intervention
period. Subjects, however, were instructed not to change
their normal diet pattern and they did not reply any
change when we asked them. Further, subjects were
instructed to maintain their normal physical activity
pattern outside the strength training. If they planned any
one-leg training outside the study they were instructed
not to do any of this training within the study period.
Monitoring of menstrual cycle integrity
In order to determine the exact individual training
and testing schedule, subjects measured their basal body
temperature every morning throughout the entire study
period at the same time before getting out of bed. The
occurrence of ovulation was defined when an increase in
basal body temperature of at least 0.3°C was measured
(Kelly 2006; Owen 1975).
Strength training program
The subjects completed three cycles of a controlled,
supervised strength training program. The training was
done four times a week: three times per week (Mondays,
Wednesdays and Fridays) under supervision on a leg press
machine and one time per week (Saturdays) at home
with the subject’s own body weight (squats). Training
participation was documented by the supervisors and
additionally subjects documented their training participation
in their training calendar. According to strong supervision,
participation rate reached 92%. On the leg press subjects
performed a one-leg sub-maximum strength training (80%
of maximum strength of the respective leg) with three sets
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of recovery between sets. More weight was added for the
leg press exercise when subject performed more than 12
repetitions. At home they performed three sets of 15–20
one-leg squats with 3–5 minutes of recovery between sets.
One leg was mainly trained in FP (FT) and the other
leg mainly in LP (LT). The strength training program
started individually with the 1st day of the menstrual
cycle. As soon as basal body temperature increased more
than 0.3°C for 3 days subjects changed their training leg.
This scheme resulted in eight times training sessions in
FP and just twice in LP in the follicular phase based
training, and in eight times training sessions in LP and
just twice in FP in the luteal phase based training session
(Table 1). The respective two training loads in LP in the
follicular phase based training (FT), and in FP in the
luteal phase based training (LT) aimed at conserving the
induced adaptation processes.
Hormone analysis
Venous blood was centrifuged after blood clotting
and the serum kept frozen at −80°C until analysis.
Each sample was analysed for estradiol (E2), P4, total
testosterone (T) and free testosterone (free T), and
dihydrotestosterone-sulfate (DHEA-s). E2, P4, T, and
DHEA-s were assayed by immunochemistry (Elecsys® 1010
System, Roche Diagnostics GmbH), and free T was analysed
by radioimmunoassay (Multi-Crystal LB 2111 gamma
counter, Berthold Technologies GmbH & Co. KG).
The Elecsys 1010 analyser is a fully automatic, run-oriented
analyser system for determination of immunological tests
using the ECL/Origen electro-chemiluminescent process.
ECL is a process in which highly reactive species are
generated from stable precursors at the surface of an elec-
trode. These highly reactive species react with one another
producing light. The system measures samples in the form
of serum and plasma. Depending on the test used, the
results are produced either as quantitative or qualitative
results. All components and reagents for routine analysis
are integrated in or on the analyser. The measurement
signals produced are used by the Elecsys 1010 to calculate
the results. The measuring cell is a sealed chamber andTable 1 Study scheme and periodization of the strength train
luteal phase-based training (LT) of the respective leg
Pre training 3 tra
1
Hormones, Mdm, Fmax,
muscle biopsy
Training program FP LP FP
FT xxxxxxxx xx xxxxxx
LT xx xxxxxxxx xx
Fmax Fmax Fmax
FP: follicular phase, LP: luteal phase, FT: follicular phase-based training, LT: luteal ph
extension, x: one single training session.consists of a working electrode, counter electrodes, a
magnet and a photomultiplier. An immunological ECL
test is made up of various pipetting steps, at least one
incubation period and a measurement step. Generally,
at least three test components (sample, reagent and
microparticles) are pipetted into an assay cup. After
the appropriate incubation period, the reaction mixture is
aspirated into the measuring cell where the measurement
process takes place. Each of these pipetting cycles is per-
formed within a defined period (approximately 60 seconds).
The Multi Crystal LB 2111 gamma counter is a compact,
robust and easy-to-use instrument for most applications
where gamma-emitting isotopes are used. The 12 detectors
are made of high-quality NaI well-type crystal providing
best measurement geometry for gamma emitters located in
the sample tubes. The principle of the analysis of free tes-
tosterone follows the basic principle of radioimmunoassay
where there is competition between a radioactive and a
non-radioactive antigen for a fixed number of antibody
binding sites. The amount of I125-labelled testosterone
analog bound to the antibody is inversely proportional to
the concentration of the free testosterone present.
For the tests and reagents used in this investigation,
the following lower detection limits were relevant: E2:
5.0 pg/mL; P4: 0.03 ng/mL; DHEA-s: 0.100 μg/dL; T:
2.5 ng/dL; free T: 0.18 pg/ml. Coefficients of variation were:
E2: 4.4% (at 149 pg/ml); P4: 2.4% (at 1.57 ng/ml); DHEA-s:
2.8% (at 117 μg/dL); T: 10.2% (at 4.49 ng/dL); free T: 6.2%
(at 1.87 pg/ml.). All blood samples from a single woman
were analysed together to avoid inter-assay variations.
Measurement of the strength of maximum isometric knee
extension (Fmax)
Fmax of the right and left leg was measured separately
once in late FP (day 11) and once in late LP (day 25) in
the 2nd control cycle and in each training cycle. Fmax
was determined on a leg press machine (Medizinische
Sequenzgeräte, Compass, Germany) using a combined
force and load cell (GSV-2ASD, ME-Messsysteme GmbH,
Hennigsdorf, Germany). Prior to testing the subjects under-
went a 10-min warm-up period of aerobic, low-resistance
ergometer cycling and were familiarized with the test anding program of the follicular phase-based (FT) and the
ining cycles Post training
2 3
LP FP LP Hormones, Mdm, muscle biopsy
xx xx xxxxxxxx xx
xxxxxxxx xx xxxxxxxx
Fmax Fmax Fmax
ase-based training, Mdm: muscle diameter, Fmax: isometric maximal force of leg
Sung et al. SpringerPlus 2014, 3:668 Page 5 of 10
http://www.springerplus.com/content/3/1/668the testing position (knee angle: 90°, ankle angle: 90°) on
the leg press. Each measurement was repeated three times
with 30 seconds of rest between the tests. The best result
was selected for data analysis. Two subjects were not able
to perform the isometric strength tests during the training
cycles because of personal reasons. A reliability analysis was
performed for the isometric measurement. The Intraclass
Correlation Coefficient was 0.998, which indicates that the
system has a high internal consistency (reliability).
Determination of muscle diameter (Mdm)
Mdm of the rectus femoris, vastus intermedius and
vastus lateralis muscle of the right and left leg was
measured by real-time ultrasound imaging prior to and
after training on day 25 in LP of the second control cycle
and the third training cycle, analysing the distances
between the outer and inner muscle fasciae using a Vivid I
CE 0344 ultrasound device (GE Medical System, Solingen,
Germany) with a parallel scanner (8 L-RS, 4.0–13.3 MHz)
which provides 10 cm penetration depth of the sound
wave and enables diagrams of deep lying muscles. The
linear measurement of the shortest distance of the muscle
depth was used. Previous studies showed that muscle
cross-sectional area might reliably be measured using
real-time ultrasound imaging (Martinson and Stokes
1991). Subjects prevented long-lasting static muscular
tension for at least 30 minutes prior to the measurement
in order to avoid alterations in Mdm (Reimer et al. 2004).
All subjects lay supine with stretched legs on an examin-
ation couch without any pad, cushion or pillow underneath.
Ultrasound images were obtained half-way between hip
bone and knee cap and the transducer was placed gently
on thighs to avoid compression and distortion of the
underlying tissue. The transducer was held at an angle of
90° to the muscle borders to ensure a clear image. The
images were displayed and frozen on the screen and they
were photographed to measure the muscle diameter. The
positions of transducer were recorded for each muscle to
reproduce the exact position after training intervention.
The means of three measurements of M. vastus medialis,
M.vastus intermedius and M. vastus lateralis were taken at
the same site for all subjects and the sum of three muscles
diameters was calculated and used for data analysis
(Mdm). Reliability analysis was performed for Mdm
determination. The obtained ICC was 0.997, indicating a
high reliability of the ultrasound imaging of Mdm used in
this study.
Histochemical analysis of muscle samples
Muscle samples (70 mg - 300 mg) were obtained from the
vastus lateralis muscle of both right and left leg by the per-
cutaneous needle biopsy technique (Bergström 1962). Nine
subjects volunteered to participate in muscle needle biop-
sies on day 27 of the second control cycle and of the thirdtraining cycle (about two days after the last training). The
muscle samples were removed from the needle and
oriented cross-sectional, mounted in a Tissue-Tek OCT
(Sakura Finetek Europe B.V., Zoeterwoude, Nederland)
embedding medium, frozen in isopentane cooled by
using liquid nitrogen, and stored at −80°C for subse-
quent histochemistry. Thin sections (10 μm) were cut
in a cryostat at −20°C and mounted on cover glasses
for staining.
Histochemical analysis for the determination of muscle
fibre types (types Ι and ΙΙ) was performed with adenosine-
triphosphatase (ATPase) staining procedures using an
alkaline pre-incubation at pH 4.3 and 9.6 (Brooke and
Kaiser 1970). Moreover, muscle cell nuclei were stained
with hematoxylin and eosin for nuclei-to-fibre (N/F) ratio
analysis (Yan 2000). Fibre type counting and measurements
were performed on photographs. For muscle fibre compos-
ition, an average of 288 fibres from each sample was
identified, and the percentage of each fibre type was
calculated. For the muscle fibre diameter averages of
62 fibres (range 20–119) from each fibre type (type Ι
and type ΙΙ) were selected and measured using Cell-D
life science documentation software (Olympus life and
material science Europe GmbH, Hamburg, Germany).Statistical analysis
Data are presented as mean values with SD. Normality
of distributions was proved by the Kolmogorov-Smirnov
test. A two-tailed paired t-test was used to evaluate
improvements in training workload, of Fmax, Mdm,
fibre composition, fibre diameter and N/F between
values before (pre) and after the training intervention
(post). ANOVA with repeated measures was used to
determine main effects of time, cycle phase, and time
by cycle phase interaction. In all cases, P values <0.05
(two-tailed paired t-test) were taken to indicate statistical
significance. The intra-class correlation coefficient of
repeated measurements (ICC) was determined to evaluate
reliability of the determination of Fmax and Mdm
(McGraw and Wong 1996, 2004). Effect size and statistical
power for changes in Fmax, Fdm, and alterations in muscle
morphological characteristics were analysed post hoc
as a function of significance level α, the respective sample
sizes, and the means and standard deviations of differences
using G*Power power analysis program (Faul et al. 2007,
Faul et al. 2009, Cohen 1988).Results
Number of training sessions
The total number of single-leg training sessions was
approximately 28 sessions per leg and was not different
between FT and LT (FT: N = 28.6 ± 1.7; LT: N = 28.1 ± 1.9;
P > 0.05).
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We did not find any significant differences in the serum
concentrations of E2 and DHEA-s between day 11 and
day 25 of the menstrual cycle prior to training, while P4
was significantly higher (effect size: 0.995, power: 0.98),
and T and free T were significantly lower on day 25
compared to day 11 (effect sizes: 0.67 and 0.81, power:
0.76, 0.88, respectively) (Table 2). After the strength
training period, E2 became significantly higher in LP
compared to FP (effect size: 0.56, power: 0.61), and P4
became higher in LP compared to LP prior to the training
intervention (effect size: 0.67, power: 0.77), while DHEA-s
remained unchanged. The differences in T and free T
between both days were no longer detectable after the
training period. T declined significantly from pre- to
post-training in FO (effect size: 0.64, power: 0.73), and
free T tended to decline from pre- to post-training in
FO (p = 0.066, effect size: 0.54, power: 0.56).Maximum isometric muscle strength
Fmax of one-leg knee extension muscles did not differ
between FO and LU prior to the training period. Fmax of
knee extension muscles increased significantly (P < 0.05)
after both types of training periodization compared to
the pre-training level (Figure 1). Absolute increase in
Fmax was significantly smaller after LT (ΔLT: 188 ± 98 N)
compared to FT (ΔFT: 267 ± 101 N) (P < 0.05, effect size:
0.87, power: 0.96). Fmax increased progressively during
FT and LT compared to the mean of both measurements
in the control cycle (Figure 2).Muscle diameter
The sum of Mdm of the three muscles increased signifi-
cantly (P < 0.05) after both types of training periodization
compared to the pre-training level. Increase in Mdm was
significantly higher after FT (ΔFT: 0.57 ± 0.54 cm) comparedTable 2 Serum concentrations of E2, P4, DHEA-s, T and
free T in the follicular phase (FP, around day 11) and the
luteal phase (LP, around day 25) before and after three
months of follicular phase-based or luteal phase-based
strength training (N = 20)
Pre-training Post-training
FP LP FP LP
E2 (pg/ml) 124 ± 104 114 ± 71 92 ± 70 142 ± 41†
P4 (ng/ml) 0.82 ± 0.53 5.66 ± 3.93† 0.78 ± 0.50 8.36 ± 3.33†*
DHEA-s (μg/ml) 2.65 ± 1.13 2.52 ± 0.83 2.55 ± 0.73 2.58 ± 0.73
T (ng/ml) 0.44 ± 0.20 0.35 ± 0.18† 0.37 ± 0.14* 0.37 ± 0.15
Free T (pg/ml) 2.57 ± 0.86 1.94 ± 0.62† 2.14 ± 0.62* 2.06 ± 0.60
E2: estradiol, P4: progesterone, T: testosterone, pre/post-training: before/after
three months of strength training.
FP: follicular phase, LP luteal phase, *: P <0.05 post training vs. pre training,
†: P <0.05 LP vs. FP.to LT (ΔLT: 0.39 ± 0.38 cm) (P < 0.05, effect size: 0.47,
power: 0.52, Figure 3).
Muscle fibre characteristics
Fibre type distribution remained nearly the same after
both kinds of strength training periodization with about
40% type I fibres and 60% type II fibres (Table 3). Fdm
increased significantly after FT in type II fibres (P < 0.05,
effect size: 0.94, power: 0.70) and tended to increase
after LT in type II fibres (P = 0.095, effect size: 0.63,
power: 0.38), but remained the same in type I fibres after
FT and LT. The N/F ratio increased significantly after
FT (P < 0.05, effect size: 0.90, power: 0.66) and remained
unchanged after LT.
Discussion
The most important finding of our study is a significantly
higher (power 0.96) increase in Fmax after FT compared to
LT (Figure 1). This is in line with the main finding of
(Reis et al. 1995) who described a higher percent increase
in Fmax after the second training cycle in the follicular
phase-trained leg compared to the regularly trained leg
(33% increase vs. 13% increase in Fmax).
The second important finding of our study is a signifi-
cantly higher (power 0.52) increase in Mdm after FT com-
pared to LT, which is in line with the higher increase in
Fmax after FT. This higher increase in Mdm after FT
may be explained by a higher ratio between protein
synthesis and protein breakdown during or after
each strength training session in FP compared to LP
(Oosthuyse and Bosch 2010).
This study is the second one to address the planning of
strength training with respect to hormonal fluctuations
during the MC and the first to include the analysis of
muscle cell parameters. We analysed the effects of a
longer-lasting training period and we clearly varied the
strength training periodization between FP and LP in
contrast to the first study (Reis et al. 1995) which
strengthens the view that menstrual cycle induced alter-
ations in hormone concentration are one probable cause
for the differences in the height of strength increase. Plasma
hormone concentrations, however, represent a balance
among production, metabolism, utilization, clearance, and
plasma volume. With our measurements we only consid-
ered one variable of a complex system, which additionally
represents just the actual concentration. To minimize
the variations in this system we strictly standardized
the conditions during blood sampling, although this
remains a limitation of the study.
The more pronounced increase in muscle strength
and muscle diameter in FT compared to LT could be
explained by the higher concentrations of T and free T
during FP compared to LP in the pre-training and
probably also first training period (Table 2), although
Figure 1 Fmax before and after three months of follicular phase-based (FT) or luteal phase-based (LT) strength training (N=20); Pre:
before training, Post: after training, *: P < 0.05 post training vs. pre training, †: P < 0.05 FT vs. LT.
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hormone concentration rather in the late follicular than in
the early follicular phase which makes interpretation of
the hormone values somewhat weak. This is another
limitation of the present investigation. Data in the literatureFigure 2 Increase in Fmax compared to the pre-training value during
training (N=18); Pre: before training, Control: control cycle, Training:
around day 25; n.s.: not significant; *: P < 0.05 compared to pre trainon variation of anabolic hormones throughout the
menstrual cycle, however, are consistent with our most
relevant findings. Since androgen secretion from the ovary
is under luteinizing hormone (LH) control, it is not
unexpected that ovarian androgen secretion varies throughfollicular phase-based (FT) or luteal phase-based (LT) strength
training cycle, Day 11: analysis around day 11; Day 25: analysis
ing, †: P < 0.05 FT vs. LT.
Figure 3 Sum of the diameters of rectus femoris, vastus intermedius and vastus lateralis muscle before and after 3 months of follicular
phase-based (FT) or luteal phase-based (LT) strength training (N=20); Pre: before training, Post: after training, *: P < 0.025 post training
vs. pre training, †: P < 0.025 FT vs. LT.
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http://www.springerplus.com/content/3/1/668the cycle: the blood levels of T have been described
as lowest in the early follicular phase and then rising
to their highest levels just prior to, or at the time of
ovulation and then gradually fall during the luteal phase
(Alexander et al. 1990; Jabbour et al. 2006; Longcope
1986). Therefore, it seems probable that they account for
differences in strength, muscle diameter, and muscle cell
characteristics between follicular- compared to luteal
phase-based strength training.
Furthermore, the higher increases in Fmax and Mdm after
FT might also be explained by menstrual cycle-dependent
alterations of estradiol and progesterone. It has long been
demonstrated that the ovarian hormones fluctuate dur-
ing the menstrual cycle (Oosthuyse and Bosch 2010;Table 3 Muscle fiber type distribution (No), fiber diameter (Fd
months of follicular phase-based or luteal phase-based streng
Pre-training
FT LT
Type Ι Type ΙΙ Type Ι Type Ι
No (%) 40.9 ± 9.1 59.1 ± 9.1 41.8 ± 13.6 58.2 ± 13
Fdm (μm) 54.5 ± 5.1 45.8 ± 5.8 54.0 ± 7.4 46.8 ± 7
N/F 2.9 ± 0.4 3.4 ± 0.8
FT: follicular phase-based training, LT: luteal phase-based training, *: P <0.025 post-Reilly 2000). E2 peaks prior to ovulation and during
LP, while P4 reaches its highest values during LP after
ovulation (Van Look and Baird 1980). The ovarian
hormones are known to have a noticeable influence on
protein metabolism at rest and during exercise. It appears
that progesterone is responsible for the consistent finding
of increased protein catabolism in LP, while estrogen might
reduce protein catabolism (Oosthuyse and Bosch 2010).
The similar concentrations in E2 around day 11 and day
25 prior to the training period in our study are probably
due to the fact that day 11 represents a phase very close to
ovulation, when E2 is already elevated compared to early
and middle FP (Van Look and Baird 1980). A time point
during the early follicular phase (around day 4 to 6) of them) and nuclei-to-fiber ratio (N/F) before and after three
th training (N = 9)
Post-training
FT LT
Ι Type Ι Type ΙΙ Type Ι Type ΙΙ
.6 40.3 ± 11.1 59.7 ± 11.1 40.5 ± 13.0 59.5 ± 13.0
.9 56.7 ± 7.1 52.5 ± 7.0* 57.0 ± 3.4 51.9 ± 7.3#
3.8 ± 1.1* 3.4 ± 0.7
training versus pre-training, #: P = 0.045 post-training versus pre-training.
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concentrations in FP compared to LP for these hormones.
This is a limitation of the study.
The higher value of E2 in LP compared to FP, the
increase in P4 in LP, and the decline in T and free T
in FP after the strength training intervention may be due
to exercise- and training-induced changes in menstrual
cycle physiology, including alterations in feedback
regulation of steroid hormones. Recently, serum estradiol
and progesterone have been shown to increase in the
mid-luteal phase, and testosterone has been shown to
decrease in the early follicular and in the mid-luteal phase
after a single bout of resistance exercise in healthy young
women, indicating that the responses of steroid hormones
to acute resistance exercise are different between hor-
mones and vary between menstrual cycle phases in young
women (Nakamura et al. 2011). The authors concluded
that the menstrual cycle state may influence the exercise
training-induced skeletal muscular adaptation, and that it
would be possible for training programs for eumenorrheic
women to be timed in accordance with the menstrual
cycle in order to maximize anabolic effects.
We found an increase in serum estradiol and P4 in LP
after 3 months of strength training, suggesting that the
acute strength training-induced increase in the luteal phase
described by Nakamura et al. (2011) might chronically lead
to an increase in serum estradiol and progesterone basal
concentration in this cycle phase. Further, we found a
decline in serum testosterone in FP after 3 months strength
training, suggesting that the acute strength training-
induced decline described by Nakamura et al. (2011) might
chronically lead to a reduction in serum testosterone basal
concentration in this phase.
A remarkable finding of the muscle biopsy analysis
was the significant increase in the type II fibre diameter
after FT compared to only a tendency for an increase after
LT. Resistance training has been shown to increase the
volumes of myofibrils, of the interfibrillar space, of mito-
chondria and lipid droplets in females (Wang et al. 1993).
An increase in the number and or size of myofibrils
requires an increase in specific protein biosynthesis, which
is dependent on anabolic agents such as testosterone and
estrogens. Therefore, the slightly higher increase in cell
diameter of type II fibres after FT compared to LT in our
study is again in line with the higher increase in muscle
strength and muscle diameter after FT compared to LT,
and the well-known menstrual cycle-dependent alterations
in anabolic hormones.
Interestingly, the N/F ratio increased after FT but
remained unaffected after LT. Enlargement of muscle
fibres is accompanied by an increase in the myonuclear
number. Existing myonuclei are able to support a certain
level of fibre hypertrophy. However, when the transcrip-
tional activity of existing myonuclei reaches its maximum,the enhancement of the number of myonuclei is thought
to become involved in the enhancement of protein
synthesis (Kadi 2008). A substantial increase in the
size of myofibres in the muscles requires the availability of
satellite cells that can provide additional myonuclei to sup-
port hypertrophy (Adams 2006). A variety of alterations in
the surrounding environment of the satellite cell, including
mechanical and growth factors, as well as hormonal
signalling including testosterone could regulate the
activation and proliferation of satellite cells (Kadi 2008).
Furthermore, sex-mediated differences in muscle-fibre
regeneration and satellite-cell numbers may be directly
attributed to estrogenic influence, and estrogen may exert
its influence on post-exercise muscle-satellite cell popula-
tions through events upstream of satellite-cell activation
(Enns and Tiidus 2010). Taken together, although spoken
with caution to not over-interpret data, our results under-
pin a possible role of hormonal alterations, both of testos-
terone and estrogens, throughout the menstrual cycle in
the process of satellite-cell incorporation-induced muscle
hypertrophy.Conclusions
In conclusion, this study demonstrated that follicular
phase-based strength training induced a greater effect
on muscle strength, muscle and type II fibre diameters,
and nuclei-to-fibre ratio compared to luteal phase-based
strength training in untrained and moderately trained
women. We recommend that eumenorrheic females
without oral contraception base the periodization of
strength training on their individual menstrual cycle.Abbreviations
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